Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

TMEM63A Knockout Hela Cell Line

The TMEM63A Knockout HeLa Cell Line is a CRISPR/Cas9-edited loss-of-function model in the HeLa background, designed for studying the mechanosensitive calcium-permeable channel TMEM63A. TMEM63A is…
Cat. No. ARG44164

TMEM63A Knockout COS1 Cell Line

The TMEM63A Knockout COS1 Cell Line is a CRISPR/Cas9-edited loss-of-function model targeting the TMEM63A gene in COS1 kidney fibroblasts derived from Chlorocebus aethiops. TMEM63A encodes…
Cat. No. ARG44163

TMEM41B Knockout A549 Cell Line

The TMEM41B Knockout A549 Cell Line is a CRISPR/Cas9-edited human A549 lung adenocarcinoma cell line with disrupted TMEM41B expression, eliminating the ER protein that mediates…
Cat. No. ARG44162

TMEM175 Knockout COS1 Cell Line

The TMEM175 Knockout COS1 Cell Line is a CRISPR/Cas9-edited cell line derived from COS1 kidney fibroblasts, offering a stable loss-of-function model for studying the lysosomal…
Cat. No. ARG44161

TMEM175 Knockout Hela Cell Line

The TMEM175 Knockout Hela Cell Line is a CRISPR/Cas9-edited HeLa derivative with targeted disruption of the TMEM175 gene, encoding a lysosomal potassium channel essential for…
Cat. No. ARG44160

Tmem151a Knockout HT22 Cell Line

The Tmem151a Knockout HT22 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the HT22 mouse hippocampal neuronal cell line, providing a loss-of-function model…
Cat. No. ARG44159

TM4SF1 Knockout PANC-1 Cell Line

The TM4SF1 Knockout PANC-1 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the human pancreatic ductal adenocarcinoma cell line PANC-1, designed to disrupt…
Cat. No. ARG44158

TLR6 Knockout HEK293T Cell Line

The TLR6 Knockout HEK293T Cell Line is a CRISPR/Cas9-edited knockout cell line derived from HEK293T human embryonic kidney epithelial cells, designed for targeted disruption of…
Cat. No. ARG44157

TLR4 Knockout HEK293T Cell Line

The TLR4 Knockout HEK293T Cell Line is a CRISPR/Cas9-edited knockout model that disrupts Toll-like receptor 4 expression in the widely used HEK293T human embryonic kidney…
Cat. No. ARG44156

TGM2 Knockout HeLa Cell Line

The TGM2 Knockout HeLa Cell Line is a CRISPR/Cas9-edited knockout cell line derived from human cervical adenocarcinoma HeLa cells, engineered to disrupt transglutaminase 2. TGM2…
Cat. No. ARG44155

TFF3 Knockout Hep-G2 Cell Line

The TFF3 Knockout Hep-G2 Cell Line is a CRISPR/Cas9-edited knockout derived from Hep-G2 hepatocellular carcinoma cells, providing a loss-of-function model for trefoil factor 3. TFF3,…
Cat. No. ARG44154

TFEB Knockout HEK293T Cell Line

The TFEB Knockout HEK293T Cell Line is a CRISPR/Cas9-edited knockout cell line that disrupts the TFEB gene in human HEK293T cells. TFEB is a master…
Cat. No. ARG44152

Loading products...